EnZeta Immunotherapies, Inc.
BiotechnologyBiotechnology / Cancer Immunotherapy
Coral Gables, FL
2023
founded
About
EnZeta Immunotherapies is an early-stage biotechnology company founded in 2023 and headquartered in Coral Gables, Florida. The company focuses on developing and commercializing T-cell-based immunotherapies for the treatment of solid tumors. Its core strategy is built upon an exclusive patent license secured from the National Institutes of Health (NIH).
Company Values
The company's primary strategic asset is its exclusive patent license from the NIH, providing it with foundational intellectual property to develop novel T-cell therapies for solid tumors.